# § 516.1012   Fuzapladib.

(a) *Specifications.* The drug is provided as a powder for injection that is reconstituted with 3.5 milliliter (mL) of provided diluent to a final concentration of 4 milligrams (mg) fuzapladib sodium per mL.


(b) *Sponsor.* See No. 064642 in § 510.600(c) of this chapter.


(c) *Conditions of use*—(1) *Amount.* Administer at a dosage of 0.4 mg (0.1 mL) per kilogram of body weight once daily for 3 consecutive days by intravenous (IV) injection over 15 seconds to 1 minute.


(2) *Indications for use in dogs.* For the management of clinical signs associated with acute onset of pancreatitis in dogs.


(3) *Limitations.* Federal law restricts this drug to use by or on the order of a licensed veterinarian. It is a violation of Federal law to use this product other than as directed in the labeling.







---

[N] [88 FR 16546, Mar. 20, 2023]








